| Title | Authors / Editors | Date |
unige:7088 |
Contribution of 20 single nucleotide polymorphisms of 13 genes to dyslipidemia associated with antiretroviral therapy |
Arnedo, Mireia; Taffe, Patrick; Sahli, Roland; Furrer, Hansjakob; ... Tarr, P. E. |
2007 |
unige:7592 |
HAART and the heart: changes in coronary risk factors and implications for coronary risk in men starting antiretroviral therapy |
Sterne, J. A.; May, M.; Bucher, H. C.; Ledergerber, Bruno; ... Egger, M. |
2007 |
unige:7603 |
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders |
Tarr, P. E.; Taffe, Patrick; Bleiber, Gabriela; Furrer, Hansjakob; ... Telenti, Amalio |
2005 |
unige:7311 |
Antiretroviral treatment and osteonecrosis in patients of the Swiss HIV Cohort Study: a nested case-control study |
Hasse, Barbara; Ledergerber, Bruno; Egger, Mathias; Egger, Martin; ... Gunthard, Huldrych |
2004 |
unige:7105 |
Abnormalities of body fat distribution in HIV-infected persons treated with antiretroviral drugs: The Swiss HIV Cohort Study |
Bernasconi, Enos; Boubaker, Karim; Junghans, Cornelia; Flepp, Markus; ... Telenti, Amalio |
2002 |
unige:7116 |
Hyperlactatemia and antiretroviral therapy: the Swiss HIV Cohort Study |
Boubaker, K.; Flepp, Markus; Sudre, Philippe; Furrer, Hansjakob; ... Telenti, A. |
2001 |
unige:7207 |
Prevalence of adverse events associated with potent antiretroviral treatment: Swiss HIV Cohort Study |
Fellay, Jacques; Boubaker, K.; Ledergerber, Bruno; Bernasconi, Enos; ... Telenti, A. |
2001 |